🇺🇸 FDA
Patent

US 11426464

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

granted A61KA61K38/51A61K45/06

Quick answer

US patent 11426464 (Engineered primate cystine/cysteine degrading enzymes as antineogenic agents) held by The Board of Regents of the University of Texas System expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/51, A61K45/06, A61P, A61P35/00